Skip to main content Deutsch


Markus Dold
Ap. Prof. Priv.-Doz. Dr. Markus Dold

Department of Psychiatry and Psychotherapy (Division of General Psychiatry)
Position: Senior physician

ORCID: 0000-0001-8914-2192


Antidepressive Agents; Antipsychotic Agents; Depression; Meta-Analysis; Obsessive-Compulsive Disorder; Schizophrenia

Research interests

Effektivität und Tolerabilität von Antidepressiva, Antipsychotika und Ketamin in der Pharmakotherapie depressiver Erkrankungen.

Effectiveness and tolerance of antidepressants, antipsychotics and ketamine in the pharmacotherapy of depressive disorders.

Selected publications

  1. Dold, M., Bartova, L. and Kasper, S. (2020) ‘Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment’, International Journal of Neuropsychopharmacology, 23(7), pp. 440–445. Available at:
  2. Dold, M. et al. (2017) ‘Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled Trials’, Psychotherapy and Psychosomatics, 86(5), pp. 283–291. Available at:
  3. Dold, M. et al. (2015) ‘Second-Generation Antipsychotic Drugs in Anorexia Nervosa: A Meta-Analysis of Randomized Controlled Trials’, Psychotherapy and Psychosomatics, 84(2), pp. 110–116. Available at:
  4. Dold, M. et al. (2015) ‘Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials’, International Journal of Neuropsychopharmacology, 18(9), p. pyv047. Available at:
  5. Dold, M. and Kasper, S. (2016) ‘Evidence-based pharmacotherapy of treatment-resistant unipolar depression’, International Journal of Psychiatry in Clinical Practice, 21(1), pp. 13–23. Available at: